295 related articles for article (PubMed ID: 30938616)
61. Malignant anal sac melanoma in dogs: eleven cases (2000 to 2015).
Vinayak A; Frank CB; Gardiner DW; Thieman-Mankin KM; Worley DR
J Small Anim Pract; 2017 Apr; 58(4):231-237. PubMed ID: 28276118
[TBL] [Abstract][Full Text] [Related]
62. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate.
Alonso-Miguel D; Valdivia G; García-San José P; Alonso-Diez Á; Clares I; Portero M; Peña L; Pérez-Alenza MD
Vet Comp Oncol; 2022 Mar; 20(1):179-188. PubMed ID: 34390295
[TBL] [Abstract][Full Text] [Related]
63. Confirmed case of Pneumocystis pneumonia in a Maltese Terrier × Papillon dog being treated with toceranib phosphate.
Best MP; Boyd SP; Danesi P
Aust Vet J; 2019 May; 97(5):162-165. PubMed ID: 31025329
[TBL] [Abstract][Full Text] [Related]
64. Hypercalcemia associated with an adenocarcinoma derived from the apocrine glands of the anal sac.
Meuten DJ; Cooper BJ; Capen CC; Chew DJ; Kociba GJ
Vet Pathol; 1981 Jul; 18(4):454-71. PubMed ID: 7257088
[TBL] [Abstract][Full Text] [Related]
65. Retrospective study of survival time and prognostic factors for dogs with small intestinal adenocarcinoma treated by tumor excision with or without adjuvant chemotherapy.
Smith AA; Frimberger AE; Moore AS
J Am Vet Med Assoc; 2019 Jan; 254(2):243-250. PubMed ID: 30605388
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of adjuvant carboplatin chemotherapy in the management of surgically excised anal sac apocrine gland adenocarcinoma in dogs.
Wouda RM; Borrego J; Keuler NS; Stein T
Vet Comp Oncol; 2016 Mar; 14(1):67-80. PubMed ID: 26811974
[TBL] [Abstract][Full Text] [Related]
67. Hypercalcaemia associated with a retroperitoneal apocrine gland adenocarcinoma in a dog.
Bertazzolo W; Comazzi S; Roccabianca P; Caniatti M
J Small Anim Pract; 2003 May; 44(5):221-4. PubMed ID: 12779174
[TBL] [Abstract][Full Text] [Related]
68. The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
Rossi F; Sabattini S; Vascellari M; Marconato L
Vet Comp Oncol; 2018 Dec; 16(4):497-504. PubMed ID: 29806156
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 and Ki67 in Apocrine Gland Anal Sac Adenocarcinoma.
Paiva F; Santos J; Carra G; Sueiro F; Jark P; Nardi A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928157
[TBL] [Abstract][Full Text] [Related]
70. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
Gustafson TL; Biller B
J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
[No Abstract] [Full Text] [Related]
71. Surgical management of primary, metastatic and recurrent anal sac adenocarcinoma in the dog: 52 cases.
Barnes DC; Demetriou JL
J Small Anim Pract; 2017 May; 58(5):263-268. PubMed ID: 28245066
[TBL] [Abstract][Full Text] [Related]
72. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
Laver T; London CA; Vail DM; Biller BJ; Coy J; Thamm DH
Vet Comp Oncol; 2018 Mar; 16(1):E23-E29. PubMed ID: 28621057
[TBL] [Abstract][Full Text] [Related]
73. Preliminary evaluation of serial (18) FDG-PET/CT to assess response to toceranib phosphate therapy in canine cancer.
Leblanc AK; Miller AN; Galyon GD; Moyers TD; Long MJ; Stuckey AC; Wall JS; Morandi F
Vet Radiol Ultrasound; 2012; 53(3):348-57. PubMed ID: 22360684
[TBL] [Abstract][Full Text] [Related]
74. Optical coherence tomography imaging of excised canine apocrine gland anal sac adenocarcinoma tumours.
Dornbusch JA; Selmic LE; Huang PC; Samuelson JP; Cocca C; Wavreille VA; Boppart SA
Vet Comp Oncol; 2021 Dec; 19(4):759-762. PubMed ID: 32562302
[TBL] [Abstract][Full Text] [Related]
75. Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasia.
Berger EP; Johannes CM; Post GS; Rothchild G; Shiu KB; Wetzel S; Fox LE
J Feline Med Surg; 2018 Feb; 20(2):95-102. PubMed ID: 29172873
[TBL] [Abstract][Full Text] [Related]
76. Ultrastructural evaluation of adenocarcinomas derived from apocrine glands of the anal sac associated with hypercalcemia in dogs.
Meuten DJ; Capen CC; Kociba GJ; Chew DJ; Cooper BJ
Am J Pathol; 1982 May; 107(2):167-75. PubMed ID: 7200729
[TBL] [Abstract][Full Text] [Related]
77. Computed tomographic staging of dogs with anal sac adenocarcinoma.
Sutton DR; Hernon T; Hezzell MJ; Meakin LB; Gould SM; Bradley KJ; Major AC
J Small Anim Pract; 2022 Jan; 63(1):27-33. PubMed ID: 34608641
[TBL] [Abstract][Full Text] [Related]
78. Hypercalcemia of malignancy: Hypercalcemia associated with an adenocarcinoma of the apocrine glands of the anal sac.
Meuten DJ; Capen CC; Kociba GJ; Cooper BJ
Am J Pathol; 1982 Sep; 108(3):366-70. PubMed ID: 7114166
[No Abstract] [Full Text] [Related]
79. Effects of Toceranib Phosphate on the Hypothalamic-Pituitary-Thyroid Axis in Tumor-Bearing Dogs.
Hume KR; Rizzo VL; Cawley JR; Balkman CE
J Vet Intern Med; 2018 Jan; 32(1):377-383. PubMed ID: 29193327
[TBL] [Abstract][Full Text] [Related]
80. Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.
Chon E; McCartan L; Kubicek LN; Vail DM
Vet Comp Oncol; 2012 Sep; 10(3):184-93. PubMed ID: 22235941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
